Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SingTa Growth Capital is an independent sponsor organization founded by executives with over 40 years of experience across various sectors, including Banking, Capital Markets, Healthcare, Technology, and Industrials. The firm operates from two major financial hubs: New York and London. This geographical presence allows SingTa to tap into diverse markets and opportunities for growth.
As an independent sponsor, SingTa Growth Capital utilizes a deal-by-deal acquisition model, distinguishing itself from traditional pooled venture funds. The firm has pre-committed capital from family offices and institutional investors, enabling it to act swiftly in identifying and acquiring promising businesses. SingTa focuses on partnering with founders to scale their businesses through strategic acquisitions, enhancing their operational capabilities and market reach.
SingTa Growth Capital invests primarily in tech-enabled industrial manufacturing and service businesses, with a strong emphasis on those that have a healthcare or bio-life sciences value proposition. The firm targets companies with revenues between USD 20 million and USD 50 million and EBITDA between USD 5 million and USD 10 million. This financial criterion ensures that SingTa engages with businesses that are poised for growth and require capital infusion to scale effectively.
The investment strategy of SingTa includes not only providing capital but also enhancing management expertise and facilitating access to new markets. This dual approach allows the firm to support its portfolio companies in achieving sustainable growth. SingTa's geographic focus spans North America and Europe, with a broader interest in markets across Africa and the Middle East, reflecting its global investment strategy.
Tanek Amin - Senior Finance and Operations Professional. Tanek has extensive experience in finance and operations, contributing to the strategic direction of SingTa Growth Capital.
Abhi Singh - Senior Finance Professional. Abhi brings a wealth of knowledge in finance, focusing on investment strategies and operational efficiency within the firm.
To pitch SingTa Growth Capital, founders should send an email to enquiries@singtagrowthcapital.com. It is recommended to include a comprehensive business plan, financial projections, and details about the management team. A clear articulation of the growth strategy and how the investment will be utilized is essential. Response times may vary, but founders should expect a thorough review process.
What are SingTa Growth Capital's investment criteria?
SingTa Growth Capital focuses on tech-enabled industrial manufacturing and service businesses, particularly in the healthcare and bio-life sciences sectors. They target companies with revenues between USD 20 million and USD 50 million and EBITDA between USD 5 million and USD 10 million.
How can founders pitch to SingTa Growth Capital?
Founders can reach out to SingTa Growth Capital via email at enquiries@singtagrowthcapital.com. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes SingTa Growth Capital different from traditional venture capital firms?
SingTa operates as an independent sponsor organization, utilizing a deal-by-deal acquisition model rather than a pooled fund structure. This allows them to be more flexible and responsive to specific investment opportunities.
What is the typical check size for investments?
SingTa Growth Capital typically invests between USD 20 million and USD 50 million in each deal, providing substantial capital to support growth initiatives.
What level of involvement does SingTa have post-investment?
SingTa Growth Capital enhances management expertise and facilitates access to new markets for its portfolio companies, indicating a hands-on approach to post-investment support.
What sectors does SingTa Growth Capital focus on?
SingTa primarily invests in healthcare, biotech, and energy sectors, with a specific interest in tech-enabled industrial businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.